Cited by 173Cytomegalovirus and herpesvirus researchT-cell and B-cell ImmunologyViral-associated cancers and disorders

Massive Load of Functional Effector CD4+ and CD8+ T Cells against Cytomegalovirus in Very Old Subjects

Open access
Vescovini, Rosanna, Biasini, Claudia, Fagnoni, Francesco F, Telera, Anna Rita, Zanlari, Luca, Pedrazzoni, Mario, Bucci, Laura, Monti, Daniela +4 more·2007·The Journal of Immunology

Abstract

A progressive, systemic, and low-grade proinflammatory status is one of the major characteristics of immunosenescence. Emerging data suggest a possible contribution of CMV, known to chronically infect a large proportion of humans, lifelong from newborns to centenarians. To test this hypothesis, we evaluated functional T cell responses to two CMV immunogenic proteins, pp65 and IE-1, in 65 chronically infected subjects aged 25–100 years. PBMC were stimulated with mixtures of peptides spanning the entire sequence of both proteins, and Ag specificity and magnitude of intracellular IFN-γ- and TNF-α-positive cells were then analyzed within both CD4+ and CD8+ T cells. Results indicate that pp65 and, to a lesser extent, IE-1 constitute major Ags against which aged people target functionally efficient T cell effector responses with massive production of Th1 cytokines and exhibition of CD107a degranulation marker. As a result, the production of IFN-γ induced in T cells by both Ags was seven to eight times greater in very old than in young subjects. The comparative analysis of pp65-specific responses in these very long-term carriers revealed a reciprocal relationship between CD4+ and CD8+ producing IFN-γ in the same individuals. These results indicate that CMV represents an important pathogen responsible for a strong immune activation in human aging. Such a remarkable burden of effector CD4+ and CD8+ T cells may be necessary to protect the elderly from CMV endogenous reactivation, but can turn detrimental by giving a substantial contribution to the proinflammatory status that accompanies the main age-related diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.179.6.4283

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Human CMV-specific memory T cells can comprise up to 50% of the total memory T cell compartment in older individuals.

    “This situation might explain why the human CMV-specific memory T cells can comprise up to 50% of the total memory T cell compartment in older individuals123,124 and leads to the hypothesis that persistent human CMV infection has a role in immunosenescence and inflammageing.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vescovini, R., Biasini, C., Fagnoni, F. F., Telera, A. R., Zanlari, L., Pedrazzoni, M., Bucci, L., Monti, D., Medici, M. C., Chezzi, C., Franceschi, C., & Sansoni, P.
Affiliations
  • University of Parma (IT)
  • Istituti Clinici Scientifici Maugeri (IT)
  • University of Florence (IT)
  • University of Bologna (IT)
Corresponding author
  • Vescovini, Rosanna
  • Biasini, Claudia
  • Zanlari, Luca
  • Pedrazzoni, Mario
  • Sansoni, Paolo
Venue
The Journal of Immunology
Published
2007-09
Volume
179
Issue
6
Pages
4283-4291
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W1553612782
Cited by
173
References
49
Citations by year
2026: 7 · 2025: 1 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 18 · 2018: 8 · 2017: 11 · 2016: 8 · 2015: 10 · 2014: 10 · 2013: 16 · 2012: 11
FWCI
9.62
Type
journal article
Language
en
Open access
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • Florence Research (University of Florence) (submittedVersion)
Funders
Regione Emilia-Romagna
Topics
  • Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Keywords
cytomegalovirus, immunosenescence, pp65, IE1, CD4+ T cells, CD8+ T cells, T cell effector responses, interferon-gamma, TNF-α, CD107a degranulation, Th1 cytokines, chronic viral infection, aging, proinflammation, cytomegalovirus reactivation, age-related diseases
MeSH terms
Adult, Aged, Aged, 80 and over, Cytomegalovirus, Cytotoxicity Tests, Immunologic, Humans, Interferon-gamma, Lymphocyte Activation, Peptides, Phosphoproteins, Tumor Necrosis Factor-alpha, Viral Matrix Proteins, Viral Proteins, CD4-Positive T-Lymphocytes, Immediate-Early Proteins, CD8-Positive T-Lymphocytes, Epitopes, T-Lymphocyte

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review